Background: Internationally, non-malignant respiratory disease (NMRD) is on the increase. However, although palliative care is recommended as an appropriate healthcare option for this client group, evidence suggests that these patients and their carers do not receive the same standards of palliative care as patients with a malignant lung condition.
Introduction
The World Health Organization (WHO) (2002) define palliative care as a holistic approach to the care of those with a life limiting illness and their carers, that relieves and prevents suffering through the early identification and assessment of physical, psychological, social and spiritual symptoms. Originally, the only patients who had access to palliative care services were those with a diagnosis of cancer and nearing the end of their life. More recently however, it has been recognised that palliative care is also applicable to patients with a nonmalignant disease, not just malignant disease (Mitchell et al. 2012) , and is an integral part of a patient's disease management (O'Neill and Fallon 1997) from diagnosis.
Non-Malignant Respiratory Disease (NMRD) is an umbrella term that includes conditions such as Interstitial Lung Disease (ILD), bronchiectasis and Chronic Obstructive Pulmonary Disease (COPD) (National End of Life Care Intelligence Network 2011). Two hundred and ten million people worldwide have a diagnosis of COPD and, although the exact amount is not known, it is estimated that millions of others have other forms of chronic respiratory diseases such as ILD and bronchiectasis (WHO 2008) . Non-malignant respiratory disease is a chronic, non-curable, progressive illness that requires appropriate treatment and palliative symptom management. Healthcare professionals (HCPs) provide palliative care in order to help improve the physical, psychosocial and spiritual well-being of patients with a lifelimiting illness, and their families (Mc Veigh 2016) . The palliative care provided by HCPs that specialise in this area is known as specialist palliative care, and these professionals provide palliative expertise, services and resources (Faull and Blankley 2015) . Generalist palliative care providers are HCPs who provide patients with palliative care however are not defined as specialists due to not having received accredited palliative care training (Gott et al. 2012 ). Although NMRD is on the increase internationally and nationally, evidence suggested that patients with NMRD and their carers do not receive the same standards of palliative care as patients with malignant respiratory disease (Goodridge et al. 2008 : Partridge et al. 2009 ).
The overall aim of this literature review was to critically discuss the current evidence base in relation to the palliative service provision for people with NMRD and their carers.
Literature Review
The search strategy within this literature review is described in Figure 1 . Papers were excluded that did not meet the inclusion criteria (table 1) . Empirical research papers were evaluated with guidance from the Critical Appraisal Skills Programme (CASP) critical appraisal tools (CASP UK 2012), to ensure a systematic and rigorous approach (Aveyard 2014). The CASP critical appraisal tools provided an evidence-based approach to assess the quality, quantity and consistency of the specific research designs employed by the empirical research included in the review (CASP UK). The literature was also additionally appraised by discussions with the research team. The use of themes was chosen by the researcher to appropriately identify the most commonly occurring issues in the literature (Aveyard 2010). 
Patient and carer's bio-psychosocial symptom needs and management
There are a number of complex symptoms associated with NMRD which can lead to reduced quality of life for these patients and their carers. Breathlessness is the symptom most commonly experienced by patients with a diagnosis of NMRD and is often the symptom found to be most distressing and severe (Ek and Ternestedt 2008 : Gysels and Higginson 2008 : Habraken et al. 2008 : Blinderman et al. 2009 : Bausewein et al. 2010 : White et al. 2011 : Janssen et al. 2011 : Bajwah et al. 2013 . For patients with advanced COPD, breathlessness can cause increased disability and impact on their quality of life (Blinderman et al. 2009 ). Gysels and Higginson (2008) argued that breathlessness can prevent patients with COPD from accessing services. Their research involved semi-structured interviews conducted with 18 patients diagnosed with moderate or severe COPD, who were experiencing problems regarding their breathlessness. Gysels and Higginson conveyed that patients had come to just adapt to their breathlessness and its restrictions as it had gradually worsened from the start of their illness. They also concluded that patients tried to hide how bad their breathlessness was as they associated it with smoking and feared that the public, and healthcare professionals (HCPs), would judge the cause of breathlessness as self-inflicted.
Participants additionally expressed that they were given little advice on how to manage their symptoms and were also offered limited treatment options. Gysel and Higginson and previous research (Hasson et al. 2008: Ek and Ternestedt 2008) have emphasised the importance of a palliative care approach for patients with advanced COPD.
Breathlessness is a symptom not isolated to patients with COPD as it can also be experienced by patients with other forms of NMRD. Bajwah et al. (2013) Evidence also suggested that NMRD can cause disease uncertainty amongst patients, family carers and HCPs (Gott et al. 2009 : Pinnock et al. 2011 : Ek et al.2015 : Sampson et al. 2015 . 
Palliative care service provision for patients with NMRD and their carer
Optimal and effective health service provision plays a key role in the delivery of effective palliative care to patients with NMRD and their carers. However research has shown that patients with NMRD, and their carers, do not always receive the palliative service provision they require (Fitzsimons et al. 2007 : Goodridge et al. 2008 : Gysels and Higginson 2008 : Habraken et al. 2008 : Roberts et al. 2008 : Partridge et al. 2009 : Buxton et al. 2010 : Goodridge et al. 2010 : Janssen et al. 2011 : Pinnock et al. 2011 : Mc Veigh et al. 2017a : Mc Veigh et al. 2017b : Rush et al. 2017 . Roberts et al. (2008) conducted a survey involving 100 acute NHS hospitals across the UK investigating the existing care, and quality of this care, available to patients with COPD. This survey highlighted that less than 50% of the hospitals involved had specialist palliative care services available in their area that included patients with COPD, leading to poor access to local specialist palliative care provision for this client group. This study's main limitation however, was that it sought the opinions of lead respiratory physicians who may have only provided what they perceived to be best practice.
In the UK, patients with NMRD can often have less access to specialist palliative care than those with a malignant lung disease (Partridge et al. 2009 ). Partridge et al. carried out a study across England, Wales and NI in which 107 respiratory physicians completed a questionnaire regarding specialist palliative care services for patients with NMRD. Findings indicated that patients with severe NMRD had less overall access to specialist palliative care services (21.5%) than those with lung cancer. The study reported that although two-thirds of hospital inpatients, inclusive of NMRD, could easily access specialist palliative care advice, there was less accessibility related to palliative medicine out-patient services. Also, only a small number of physicians involved in the study reported easy access to hospice day or inpatient care for patients with NMRD. The study's reliability may be questioned as the validity of the questionnaire is not discussed. Also, as previously mentioned in relation to other studies, its results were based on the views of respiratory physicians alone and the study may have gained a greater insight into this phenomenon by involving other members of the multidisciplinary team.
The geographical area a patient diagnosed with NMRD lives in can also influence the level of palliative care service provision they receive (Goodridge et al. 2010) . Goodridge et al. (2010) undertook a cohort study retrospectively investigating the healthcare data of 1098 patients who died of a respiratory illness in Canada. This was a novel study as it aimed to examine the rural-urban differences in healthcare utilisation, or location of death for patients who died of COPD or lung cancer. Results conveyed that patients in their last year of life living in rural areas were less likely to receive physician visits and home care services than those in urban areas. However, this study did not investigate the reasons for the differences in the palliative care provided in rural and urban areas. Palliative care provision for NMRD in rural and urban areas needs to be further explored, and future research should not only take into account the patients and carers perspective but also the views of HCPs regarding the delivery of generalist and specialist palliative care to these patients. This will help to provide an insight into what are the barriers and facilitators associated with providing care to patients with NMRD in rural and urban areas. Higginson et al. (2014) conducted a randomised controlled trial (RCT) in the UK assessing the effectiveness of integrating specialist palliative care early for patients with advanced disease. Fifty-four percent of participants had a diagnosis of COPD (n = 57), 20% cancer (n=21), 18 % ILD (n = 19), 5% heart failure (n=5) and 3% had another form of advanced disease (n-=3). The involvement of specialist palliative care early in the disease trajectory of patients with ILD can help manage their physiological and psychosocial symptoms (Higginson et al. ) . This RCT demonstrated that patients with ILD and COPD who received early specialist palliative care involvement experienced alleviated breathlessness and increased short term survival: 100% (n=29) vs. 79% (n=22) for COPD, and 100% (n=7) vs.
67% (n = 8) for ILD at 180 days post commencement of the study. Further investigation with this population is required however to illuminate the effects of early specialist palliative care on long term survival, findings that have previously been identified in patients with lung cancer (Temel et al. 2010) . Although previous research has recommended the involvement of specialist palliative care for patients with ILD : Bajwah et al. 2013 , referrals to specialist care are often low for this patient group (Bajwah et al. 2013 : Lindell et al. 2015 : Mc Veigh et al. 2017 
Conclusions
Evidence suggested disparities in the provision of specialist and generalist palliative care to patients with NMRD, in comparison to those with a malignant diagnosis. This review of the literature has highlighted that there are several gaps in the current research involving the palliative care provided to patients with NMRD. Further research is required to provide a deeper insight into the palliative care provision experienced by those diagnosed with ILD and Bronchiectasis alongside COPD, as the majority of research investigates COPD alone.
Key Points
 Evidence suggested that patients with NMRD and their carers do not receive the same standards of palliative care as patients with malignant respiratory disease.
 Family caregivers also require holistic care.
 There is a lack of evidence regarding palliative care for ILD and bronchiectasis.
 Future policy needs to acknowledge the role of palliative care for patients with all forms of NMRD, and their carers, and ensure optimal implementation in clinical practice.
